Reiter, Yoram

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer

Goshen-Lago, T., Waldhorn, I., Holland, R., Szwarcwort-Cohen, M., Reiner-Benaim, A., Shachor-Meyouhas, Y., Hussein, K., Fahoum, L., Baruch, M., Peer, A., et al. (2021) · JAMA Oncology

SARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impacts

Cited by 147

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation

Oved, K., Olmer, L., Shemer-Avni, Y., Wolf, T., Supino-Rosin, L., Prajgrod, G., Shenhar, Y., Payorsky, I., Cohen, Y., Kohn, Y., et al. (2020) · EClinicalMedicine

SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 Research

Cited by 129